Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-24

Clinical Trial Update: Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the onset-of-action timing of flurbiprofen using a placebo-controlled design in acute pharyngitis and sore throat; results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flurbiprofen (flurbiprofen)

Snippet

Sponsor: Reckitt Benckiser LLC | Conditions: Acute Pharyngitis, Sore Throat | Phase 3 | Status: COMPLETED | Results posted: 2017-08-24